Adamis Pharmaceuticals Corp. buy Langfinger
Start price
23.01.21
/
0%
€105.00
Target price
23.01.22
-
Performance (%)
-46.33%
End price
19.11.21
€56.35
Summary
This prediction ended on 19.11.21 with a price of €56.35. The BUY prediction by Langfinger for Adamis Pharmaceuticals Corp. performed very badly with a performance of -46.33%. This prediction was marked as speculative and is excluded from Langfinger's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamis Pharmaceuticals Corp. | - | - | - | - |
| iShares Core DAX® | 0.789% | 1.975% | 13.390% | 49.835% |
| iShares Nasdaq 100 | 4.226% | 4.344% | 39.717% | 89.762% |
| iShares Nikkei 225® | 3.285% | 6.991% | 49.894% | 64.380% |
| iShares S&P 500 | 2.496% | 2.759% | 30.229% | 64.245% |
Comments by Langfinger for this prediction
In the thread Adamis Pharmaceuticals Corp diskutieren
Buy Adamis Pharmaceuticals Corp